Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 333 followers

Latest posts

Last updated about 3 hours ago

EMA/PE/0000232774

about 3 hours ago

EMA/PE/0000232774

EMEA-003435-PIP02-23

about 3 hours ago

EMEA-003435-PIP02-23

EMEA-003489-PIP01-23

about 3 hours ago

EMEA-003489-PIP01-23

EMEA-003489-PIP02-23

about 3 hours ago

EMEA-003489-PIP02-23

EMA/PE/0000182928

about 3 hours ago

EMA/PE/0000182928

EMA/PE/0000232757

about 3 hours ago

EMA/PE/0000232757

Declaration of interests: Virginia Rojo Guerra

about 10 hours ago

Declaration of interests: Virginia Rojo Guerra

Declaration of interests: Silvy da Rocha Dias

about 9 hours ago

Declaration of interests: Silvy da Rocha Dias

Human medicines European public assessment report (EPAR): Aquipta, atogepant, Date of authorisation: 11/08/2023, Revision: 6, Status: Authorised

about 3 hours ago

Human medicines European public assessment report (EPAR): Aquipta, atogepant, Date of authorisation...

Human medicines European public assessment report (EPAR): Suliqua, insulin glargine,lixisenatide, Date of authorisation: 11/01/2017, Revision: 15, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): Suliqua, insulin glargine,lixisenatide, Date of...

Human medicines European public assessment report (EPAR): Xtandi, enzalutamide, Date of authorisation: 21/06/2013, Date of refusal: 26/04/2013, Revision: 28, Status: Authorised

about 6 hours ago

Human medicines European public assessment report (EPAR): Xtandi, enzalutamide, Date of authorisation...

EMA steps up efforts on medicines for women’s health

about 6 hours ago

EMA steps up efforts on medicines for women’s health